ARTICLE | Clinical News
BIOD-Stable Glucagon regulatory update
April 16, 2012 7:00 AM UTC
The European Commission granted Orphan Drug designation for Biodel's BIOD-Stable Glucagon to treat congenital hyperinsulinism. Biodel expects to start a Phase I trial in 4Q12 evaluating the injectable...